Search research articles
Contact Us
Filters
Showing results (41-50 of 657) with videos related to
Page
of 66
Sort By:
Diabetes
|
February 1, 1997
Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex
R G Bennett, F G Hamel, W C Duckworth
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
February 1, 1997
The significance of intracellular insulin to insulin action
W C Duckworth, R G Bennett, F G Hamel
Lipids
|
October 1, 1983
Changes in renal phospholipid fatty acids in diabetes mellitus: correlation with changes in adenylate cyclase activity
D L Clark, F G Hamel, S F Queener
Diabetes
|
April 1, 1991
Degradation of intraendosomal insulin by insulin-degrading enzyme without acidification
F G Hamel, M J Mahoney, W C Duckworth
World Journal of Gastroenterology
|
June 28, 2017
Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis
Robert G Bennett, Ronda L Simpson, Frederick G Hamel
Biochemical and Biophysical Research Communications
|
July 29, 1994
Identification and isolation of a cytosolic proteolytic complex containing insulin degrading enzyme and the multicatalytic proteinase
R G Bennett, F G Hamel, W C Duckworth
Bioactive Materials
|
February 25, 2026
Innovative strategies for diabetic peripheral neuropathy: From clinical management to emerging bioengineering solutions
Zhi He, Jie Diao, Frederick G Hamel, et al.
Biochemical and Biophysical Research Communications
|
March 26, 1998
Insulin acts intracellularly on proteasomes through insulin-degrading enzyme
W C Duckworth, R G Bennett, F G Hamel
Genetic Counseling (Geneva, Switzerland)
|
January 1, 1993
Genetic amniocentesis: a six-years experience in an isolated region of northeastern Quebec (Canada)
G Hamel, L Simard, R Gagné, et al.
Endocrine Reviews
|
October 30, 1998
Insulin degradation: progress and potential
W C Duckworth, R G Bennett, F G Hamel
Page
of 66
Search research articles
Search
Showing results (41-50 of 657) with videos related to
Sort By:
Page
of 66
Diabetes
|
February 1, 1997
Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex
R G Bennett, F G Hamel, W C Duckworth
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
February 1, 1997
The significance of intracellular insulin to insulin action
W C Duckworth, R G Bennett, F G Hamel
Lipids
|
October 1, 1983
Changes in renal phospholipid fatty acids in diabetes mellitus: correlation with changes in adenylate cyclase activity
D L Clark, F G Hamel, S F Queener
Diabetes
|
April 1, 1991
Degradation of intraendosomal insulin by insulin-degrading enzyme without acidification
F G Hamel, M J Mahoney, W C Duckworth
World Journal of Gastroenterology
|
June 28, 2017
Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis
Robert G Bennett, Ronda L Simpson, Frederick G Hamel
Biochemical and Biophysical Research Communications
|
July 29, 1994
Identification and isolation of a cytosolic proteolytic complex containing insulin degrading enzyme and the multicatalytic proteinase
R G Bennett, F G Hamel, W C Duckworth
Bioactive Materials
|
February 25, 2026
Innovative strategies for diabetic peripheral neuropathy: From clinical management to emerging bioengineering solutions
Zhi He, Jie Diao, Frederick G Hamel, et al.
Biochemical and Biophysical Research Communications
|
March 26, 1998
Insulin acts intracellularly on proteasomes through insulin-degrading enzyme
W C Duckworth, R G Bennett, F G Hamel
Genetic Counseling (Geneva, Switzerland)
|
January 1, 1993
Genetic amniocentesis: a six-years experience in an isolated region of northeastern Quebec (Canada)
G Hamel, L Simard, R Gagné, et al.
Endocrine Reviews
|
October 30, 1998
Insulin degradation: progress and potential
W C Duckworth, R G Bennett, F G Hamel
Page
of 66